- Jan 13
Our expert weighs in on the relationship between alcohol and ED
At MAC we have expertise in a wide range of different areas including Men and Women’s Health. One of these areas we have active studies...
- Dec 27, 2022
A proud year: Looking back on 2022
As we approach the end of the year, it’s only natural to reflect on the previous 12 months, whether from a personal or professional...
- Oct 18, 2022
Keeping the patient at the heart of our research
Keeping the patient at the heart of our research: My take-homes from speaking at the C3 Summit discussing inclusivity and diversity in...
- Sep 1, 2022
MAC Clinical Research appointed to conduct psychedelic trial for Major Depressive Disorder (MDD)
SmallPharma, a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions has enlisted MAC...
- Aug 26, 2022
Continuing our legacy for more than 30 years with our free memory clinics
At MAC, we have a proud history of establishing one of the UK’s first ever memory clinics back in 1988. Whilst we now operate as a...
- Jul 25, 2022
Could psychedelic research be a promising new step in treating mental health disorders?
The next generation of treatment? Could psychedelic research be a promising new step in treating mental health disorders like depression,...
- May 10, 2022
MAC receives recognition by BritishAmerican Business (BAB) as part of Transatlantic Growth Campaign
The Transatlantic Growth campaign (TAG) is an annual campaign that highlights and celebrates businesses that demonstrate growth and...
- Apr 22, 2022
MAC Featured in The Guardian Newspaper
MAC Clinical Research featured in a recent Guardian article titled: Clinical trials: how taking the pills may pay those bills. The...
- Jan 25, 2022
MAC Opens US Office/Study Site
To continue to meet the research needs of our clients and their patients across the globe, MAC Clinical Research has arrived in the...
- Jun 16, 2021
MAC Clinical Research has been appointed to accelerate timeline of Phase I/IIa clinical trial
Small Pharma Inc., a neuro-pharmaceutical company focused on psychedelic-assisted therapy, have announced the expansion of its phase...
